We are live on ! Find out more
SCA

Spearhead Capital Advisors Portfolio holdings

AUM $92.3M
1-Year Est. Return 18.16%
This Fund
S&P 500
This Quarter Est. Return
+7.56%
1 Year Est. Return
-18.16%
3 Year Est. Return
+25.24%
5 Year Est. Return
+54.04%
10 Year Est. Return
–
AUM
$735M
AUM Growth
+$57.8M
Cap. Flow
+$11.1M
Cap. Flow %
1.5%
Top 10 Hldgs %
31.1%
Holding
195
New
10
Increased
148
Reduced
29
Closed
4

Top Buys

Rank Stock Value
1
GBDC icon
Golub Capital BDC
GBDC
+$2.33M
2
AAPL icon
Apple
AAPL
+$1.25M
3
BE icon
Bloom Energy
BE
+$903K
4
MLPB icon
ETRACS Alerian MLP Infrastructure Index ETN Series B due Apr 2 2040
MLPB
+$552K
5
CRM icon
Salesforce
CRM
+$365K

Top Sells

Rank Stock Value
1
KNSA icon
Kiniksa Pharmaceuticals
KNSA
+$2.15M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$601K
3
GNMK
GenMark Diagnostics, Inc
GNMK
+$576K
4
GLUU
Glu Mobile Inc.
GLUU
+$503K
5
MRNA icon
Moderna
MRNA
+$495K

Sector Composition

Rank Sector Weight
1 Technology 15.29%
2 Healthcare 12.02%
3 Consumer Staples 10.97%
4 Financials 10.35%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RAMP icon
176
LiveRamp
RAMP
$2.3B
$308K 0.04%
6,565
+1,346
+26% +$64.7K
FOLD
177
DELISTED
Amicus Therapeutics
FOLD
$306K 0.04%
31,692
+6,555
+26% +$64K
VNQ icon
178
Vanguard Real Estate ETF
VNQ
$39.2B
$292K 0.04%
2,869
-129
-4% -$12.8K
ALLO icon
179
Allogene Therapeutics
ALLO
$649M
$289K 0.04%
+11,077
New +$316K
SNN icon
180
Smith & Nephew
SNN
$13.3B
$271K 0.04%
6,236
-509
-8% -$21.4K
IDRV icon
181
iShares Self-Driving EV and Tech ETF
IDRV
$125M
$270K 0.04%
+5,444
New +$259K
IHAK icon
182
iShares Cybersecurity and Tech ETF
IHAK
$1B
$270K 0.04%
+6,260
New +$256K
F icon
183
Ford
F
$58.5B
$269K 0.04%
18,075
– –
NEE icon
184
NextEra Energy
NEE
$181B
$269K 0.04%
3,671
+5
+0.1% +$375
SO icon
185
Southern Company
SO
$109B
$269K 0.04%
4,450
+150
+3% +$9.59K
OC icon
186
Owens Corning
OC
$11.2B
$256K 0.03%
2,613
-2,642
-50% -$264K
VGSH icon
187
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$229K 0.03%
3,726
+365
+11% +$22.5K
VCSH icon
188
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$228K 0.03%
2,759
+282
+11% +$23.3K
VWOB icon
189
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.15B
$228K 0.03%
2,853
+260
+10% +$20.6K
SHOP icon
190
Shopify
SHOP
$152B
$224K 0.03%
+1,530
New +$189K
VEA icon
191
Vanguard FTSE Developed Markets ETF
VEA
$229B
$211K 0.03%
4,086
– –
LULU icon
192
lululemon athletica
LULU
$13.5B
– –
-1,023
Closed -$314K
NKE icon
193
Nike
NKE
$61.9B
– –
-2,629
Closed -$349K
GLUU
194
DELISTED
Glu Mobile Inc.
GLUU
– –
-40,330
Closed -$503K
GNMK
195
DELISTED
GenMark Diagnostics, Inc
GNMK
– –
-24,082
Closed -$576K
4 5 6 7
8

Similar funds

AAM
Artha Asset Management Hoboken, New Jersey $90.3M AUM 27.66% 1-Year Est. Return
AEPBI
AH Equity Partners Bio III Menlo Park, California $95M AUM 50.1% 1-Year Est. Return
MW
Milestone Wealth Buffalo, New York $89.5M AUM 17.2% 1-Year Est. Return
SC
Sarissa Consulting Santa Monica, California $96.9M AUM 29.32% 1-Year Est. Return
NIM
NuWave Investment Management Parsippany, New Jersey $87.2M AUM 38.54% 1-Year Est. Return
WIM
Wilen Investment Management Bonita Springs, Florida $98.1M AUM 2.08% 1-Year Est. Return
LAM
LFS Asset Management San Ramon, California $99.1M AUM
EFEM
Eos Focused Equity Management New York $84.5M AUM 17.48% 1-Year Est. Return

Spearhead Capital Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Spearhead Capital Advisors held 195 positions worth $735M, up 8.5% from $677M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Spearhead Capital Advisors's Q2 2021 filing shows 10 new, 148 increased, 29 reduced and 4 closed positions. Its largest new stake was Golub Capital BDC: 150,000 shares worth $2.31M. The largest sale was Kiniksa Pharmaceuticals, an estimated $2.15M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Spearhead Capital Advisors's largest Q2 2021 buy was Golub Capital BDC: 150,000 shares worth $2.31M.
  • Spearhead Capital Advisors added most to Apple in Q2 2021, an estimated $1.25M increase.
  • Spearhead Capital Advisors's biggest Q2 2021 reduction was Kiniksa Pharmaceuticals, cutting an estimated $2.15M.
  • Spearhead Capital Advisors fully exited GenMark Diagnostics, Inc in Q2 2021, selling an estimated $576K.
  • Spearhead Capital Advisors's ten largest holdings make up 31% of its $735M portfolio in Q2 2021.
  • Spearhead Capital Advisors opened 10 new positions and closed 4 in Q2 2021.
  • Spearhead Capital Advisors's portfolio value rose 8.5% quarter-over-quarter to $735M.

Based on Spearhead Capital Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.